Pathways to Parity Program Approved for $250K PCORI Engagement Award
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C.
August 13, 2024
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C.
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C.
Information revealed at the 2024 AAIC conference on the ACTC-DS-led study in DS-associated Alzheimer’s disease with Lilly’s anti-amyloid drug Kisunla.
In honor of Collin Lis, a kind and loving 11-year-old boy with Down syndrome, LuMind IDSC is presenting the Collin
In honor of Collin Lis, a kind and loving 11-year-old boy with Down syndrome, LuMind IDSC is presenting the Collin
Dental care is important for everybody, but people with Down syndrome can have a number of differences that can require
This Getting an IV Visual explains what happens when we have to get an intravenous line (IV). This visual can
FDA issues approval for Kisunla, new Alzheimer’s drug; Down syndrome community optimistic On Tuesday, July 2, the U.S. Food and
Graduation from high school is a major accomplishment in the journey we each experience through life. According to the U.S.
Graduation from high school is a major accomplishment in the journey we each experience through life. According to the U.S.